| Medical and Health Sciences | 2021-2025 | 533 | NZ 2 | 99.88 |
| Nephrology | Lifetime | 40 | NZ 1 | 99.68 |
| Rheumatology | Lifetime | 202 | NZ 1 | 99.19 |
| Orthopedics and Sports Medicine | Lifetime | 778 | NZ 8 | 90.01 |
| Rehabilitation | Lifetime | 783 | NZ 8 | 82.12 |
| Nephrology | 2021-2025 | 13 | NZ 1 | 99.70 |
| Rheumatology | 2021-2025 | 91 | NZ 1 | 97.83 |
| Surgery | 2021-2025 | 347 | NZ 1 | 97.50 |
| Gout, Hyperuricemia, Uric Acid | Lifetime | 8 | NZ 1 | 99.44 |
| Urticaria and Related Conditions | Lifetime | 30 | NZ 1 | 99.48 |
| Case Reports on Hematomas | Lifetime | 7 | NZ 1 | 99.48 |
| Inflammasome and immune disorders | Lifetime | 55 | NZ 1 | 99.09 |
| Musculoskeletal synovial abnormalities and treatments | Lifetime | 30 | NZ 1 | 99.44 |
| Spondyloarthritis Studies and Treatments | Lifetime | 38 | NZ 1 | 99.43 |
| Alcohol Consumption and Health Effects | Lifetime | 140 | NZ 1 | 98.53 |
| Bone and Joint Diseases | Lifetime | 284 | NZ 5 | 97.67 |
| Eosinophilic Disorders and Syndromes | Lifetime | 311 | NZ 2 | 97.61 |
| Rheumatoid Arthritis Research and Therapies | Lifetime | 607 | NZ 4 | 97.64 |
| Veterinary medicine and infectious diseases | Lifetime | 176 | NZ 2 | 96.66 |
| Heterotopic Ossification and Related Conditions | Lifetime | 73 | NZ 1 | 94.17 |
| Pelvic and Acetabular Injuries | Lifetime | 971 | NZ 3 | 95.40 |
| Musculoskeletal Disorders and Rehabilitation | Lifetime | 501 | NZ 4 | 88.29 |
| Omental and Epiploic Conditions | Lifetime | 48 | NZ 1 | 83.38 |
| Bartonella species infections research | Lifetime | 323 | NZ 1 | 84.12 |
| Dermatological and COVID-19 studies | Lifetime | 654 | NZ 2 | 78.33 |
| Medicinal plant effects and applications | Lifetime | 788 | NZ 7 | 76.66 |
| Gout, Hyperuricemia, Uric Acid | 2021-2025 | 2 | NZ 1 | 99.37 |
| Case Reports on Hematomas | 2021-2025 | 1 | NZ 1 | 99.40 |
| Inflammasome and immune disorders | 2021-2025 | 36 | NZ 1 | 97.74 |
| Urticaria and Related Conditions | 2021-2025 | 31 | NZ 1 | 98.46 |
| Musculoskeletal synovial abnormalities and treatments | 2021-2025 | 35 | NZ 1 | 94.04 |
| Liver Disease Diagnosis and Treatment | 2021-2025 | 938 | NZ 4 | 96.03 |
| Spondyloarthritis Studies and Treatments | 2021-2025 | 104 | NZ 1 | 96.73 |
| Alcohol Consumption and Health Effects | 2021-2025 | 176 | NZ 1 | 92.75 |
| Hepatitis C virus research | 2021-2025 | 450 | NZ 3 | 93.15 |
| Veterinary medicine and infectious diseases | 2021-2025 | 49 | NZ 1 | 89.23 |
| Biosimilars and Bioanalytical Methods | 2021-2025 | 484 | NZ 3 | 82.57 |
| Alkaline Phosphatase Research Studies | 2021-2025 | 47 | NZ 1 | 73.71 |
| Bone and Joint Diseases | 2021-2025 | 755 | NZ 2 | 73.95 |
| Dermatological and COVID-19 studies | 2021-2025 | 238 | NZ 1 | 72.85 |
| Eosinophilic Disorders and Syndromes | 2021-2025 | 925 | NZ 2 | 73.51 |
| Musculoskeletal Disorders and Rehabilitation | 2021-2025 | 307 | NZ 3 | 66.86 |
| Bartonella species infections research | 2021-2025 | 197 | NZ 3 | 47.60 |
| Therapeutic Uses of Natural Elements | 2021-2025 | 881 | NZ 2 | 19.56 |
